This website is intended for Brunei Healthcare Professionals only
Molnupiravir Capsule 200mg
Each capsule contains 200 mg molnupiravir
Each bottle contains 40 capsules
Have a question about an MSD product or want to report an Adverse Event or Quality Issue?
Adverse Events and Product Quality Complaints should be reported.
IF YOU ARE A HEALTHCARE PROFESSIONAL:
Report to MSD at Fax – +65-63966883 or Email – firstname.lastname@example.org.
Please add ‘4482-PLPA-001’ to your report.
For local health authority, please report:
Adverse event via email@example.com using the Suspected Adverse Drug Reaction Report Form
Quality Issue via firstname.lastname@example.org using the Medicinal Product Quality Reporting Form
For medical inquiries, contact MSD at email@example.com.
Authorization for molnupiravir is provided by Brunei Darussalam Medicines Control Authority via special approval during public health emergency or pandemic situation. This is only a temporary authorization and is not a marketing authorization.
Copyright © 2022 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. All rights reserved.